Switching to Tenofovir Versus Continuing Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response During Entecavir Therapy: STEEP Study
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Entecavir (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms STEEP
- 08 Nov 2016 Status changed from recruiting to completed.
- 27 Feb 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 03 Mar 2013 Planned End Date changed from 1 Aug 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov.